Methods for Protease Assay
We used an HPLC assay to assess protease stability. 4 Peptide solutions were prepared in water, and their concentration was determined by UV--vis. Two nmoles of peptide was distributed into 1.7 mL eppendorf tubes and lyophilized (6 eppendorf tubes were prepared for each peptide, 3 replicates per protease). Peptides were reconstituted in 40 µL of TBS pH 8.0 (resulting concentration of peptide 40 µM) before protease was added. Chymotrypsin was purchased from Promega (catalog # V1062) and Neprilysin was purchased from Reprokine (catalog # RKP08473). Both came in pre--weighed vials (25 µg of chymotrypsin and 20 µg of NEP), and 100 µL of water was added to form the stock solution of the respective protease. For the chymotrypsin test, 40 µL of TBS buffer was added to 2 nmoles of lyophilized peptide, and 10 µL of 250 µg/mL chymotrypsin was added (final conc 50 µg/mL). For the NEP test, 40 µL of TBS buffer was added to 2 nmoles of lyophilized peptide, and 10 µL of 200 µg/mL of NEP was added (final concentration 40 µg/mL). Both reactions were at room temperature. The reaction was timed and quenched by removing 10 µL of solution and pipetting it into 100 µL of 1%TFA solution (5 data points could be taken per sample). A portion (100 µL) of the quenched reaction solution was injected into an HPLC (see peptide synthesis, analytical conditions), and peaks were analyzed. The time course of peptide degradation was experimentally determined by integrating the area of each peak in a series of HPLC traces. The final 10 µL of the quenched reaction solution was used to acquire MALDI--TOF and MS--MS data for identification of each peptide fragment. Each protease test was repeated a second time to ensure the half--life obtained was reproducible with the given conditions. Shown below are time course data for peptide degradation (exponential decay curves and half lives were calculated using GraphPad Prism) as well as the protease cleavage sites in each substrate (solid lines in peptide key; based on MS data). Analogues of GLP-1(7-37)-NH 2 that contain Aib at position 8 are reported not to be substrates for DPP-4; 4 therefore, we expected that α/β-peptide 6 would not be a DPP-4 substrate. To test this hypothesis, we purchased DPP-4 from EMD Biosciences (catalogue # 317640) as a stock solution in 20 mM Tris-HCl, 5 mM CaCl , 1 µM ZnCl , 0.05% NaN 3 pH 8.0. A 10 µL aliquot of this stock solution was added to 2 nmoles of GLP-1(7-37)-NH 2 or α/β-peptide 6 dissolved in 40 µL of TBS buffer, pH 8.0. The DPP-4 reaction was allowed to proceed at 37 o C (higher than for the other proteases because of the low DPP-4 concentration). The half-life of GLP-1(7-37)-NH 2 was 13.5 minutes under these conditions (data shown below). The solution containing α/β-peptide 6 and DPP-4 was monitored for 7 days; no cleavage was detected during this time. o C. The reaction was terminated by the addition of 1.2 M trichloroacetic acid (TCA), followed by neutralization with 4 N KOH. Cyclic AMP was isolated by the twocolumn chromatographic method. 6 Radioactivity was counted in a scintillation counter. EC 50 values were determined by sigmoidal curve fitting using GraphPad Prism version 5.0.
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Supplementary Figure 18:
GLP-1R activation, as measured by cAMP production, for GLP-1(7-36)-NH 2 and α/β-peptides 2-6. 
Method for detecting Insulin Secretion of Isolated Islet Cells from Mice
Ex vivo insulin secretion studies were performed as previously described. 7, 8 Briefly, intact pancreatic islets were isolated from ~10 week-old male B6 mice using a collagenase digestion procedure. 9 Islets are individually hand-picked using a stereomicroscope with trans-illumination to ensure that healthy, clean and acinar-free islets were used for study. To monitor glucosestimulated insulin secretion (GSIS), 3 individual islets were placed into mesh baskets made from 12 X 75 mm borosilicate tubes. Each tube had a ~5 mm hole cut in the bottom that was covered with a 62 µm mesh (Tetko). Islet selection was conducted at room temperature in Krebs Ringer Bicarbonate Buffer (KRB) containing 16.7 mM glucose, and 0.2% RIA-grade BSA (Sigma). The mesh-bottom tube containing 3 islets was transferred to a 16X100 mm tube containing 1.0 mL KRB containing 1.7 mM glucose, and 0.5% RIA-grade BSA, and pre-incubated at 37°C for 45 mins. Following the pre-incubation period, the mesh tubes were transferred to a fresh 16 X 100 mm tube containing 1.0 mL KRB containing glucose, GLP-1 or the α/β-peptide 6 at the indicated concentrations, and incubated for an additional 45 mins to allow for insulin secretion. At the end of the 45 min incubation period, the islets and media were collected from each tube and used for insulin measurements by ELISA. Insulin secretion is expressed as the fraction of total insulin present for each sample (insulin medium /insulin total ). 
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Method for Glucose Tolerance Test
GLP-1(7-37)-NH 2 , exendin-4 or α/β-peptide 6 was administered to mice by interperitoneal (i.p.) injection at a 1 mg/kg dose, or lower for α/β-peptide 6, using an injection volume of 10 mL/kg body mass. Each peptide was first dissolved in prefiltered DMSO at 10 mg/mL concentration, then diluted >20-fold with TBS buffer, pH 7.4 (final DMSO conc. = <5%). Glucose was administered by i.p. injection with a sterile-filtered 30% D-glucose-saline solution at a 1.5 g/kg dose using a 5 mL/kg injection volume.
Thirteen-week-old male C57BL/6J mice (n = 4) were fasted overnight on wood chip bedding for 15 hours prior to the experiment. Blood glucose levels were monitored from a tail tip bleed using an ACCU-CHEK Aviva blood glucose meter. Fasting glucose levels were measured at 75 minutes prior to the glucose injection (t = -75 min), and the compound injection was performed 60 minutes prior to the glucose injection (t = -60 min). Glucose levels were measured immediately prior to the glucose injection (t = 0 min) to assess any changes in the baseline glucose caused by peptide administration. Blood glucose levels were monitored at 30, 60, 90, and 120 minutes after injection of glucose.
Five hours after peptide injection, the mice received a second injection of 1.5 g/kg glucose. Blood glucose was monitored at 30 min after this second glucose injection. Mice were sacrificed by CO 2 inhalation at the conclusion of the GTT. .=J+B;T+I*;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; $IOBCONC;%)M+OI+QB;QU;I*);')OB;6$%&'8
